Tag: solid tumors

A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...

A new review maps the rapid rise of NK cell immunotherapy for solid tumors and warns that its cardiovascular safety ...

UCLA researchers used a genome-wide CRISPR screen to identify the Cullin-5 RING E3 ligase complex as a key driver of ...

A new review in Molecular Biology Reports surveys how engineered CAR-T, TCR, TIL, NK and NKT cell therapies, gene editing, ...

Researchers report that adding interleukin-18 to cultures of scarce human Vδ1 T cells boosts their expansion, survival and antitumor performance ...

A meta-analysis of 41 studies and 3,058 patients shows that detectable circulating tumor DNA after neoadjuvant therapy strongly predicts worse ...

A large target trial emulation found that cancer patients on SSRIs while receiving immune checkpoint inhibitors had significantly lower two-year ...

A study of nearly 40,000 cancer patients found that age-based germline genetic testing policies would miss about 72 percent of ...

Researchers in Seoul have developed a four-variable prediction model combining procalcitonin, pulse rate, neutrophil-to-lymphocyte ratio, and albumin that accurately identifies ...

A fourteen-year Brazilian cohort study of nearly 29,000 cancer patients found hepatitis B virus seroprevalence fell from 16.5 to 9.9 ...

A new review details how chimeric antigen receptor-engineered macrophages are overcoming the barriers that stalled CAR-T therapy in solid tumors, ...

A new review proposes co-designing oncolytic viruses and CAR-T or CAR-NK cells as a modular, self-amplifying therapeutic system to overcome ...

Effective against blood cancers, natural killer cells also may be effective against solid tumors An immunotherapy based on supercharging the ...